by FiveSenses | Sep 12, 2023 | News Release
Vancouver, BC, Canada, September 12th, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), one of the leading Canadian biotechnology companies, is pleased to announce its continuation to bringing innovative strategies aimed at targeting various... 
by FiveSenses | Sep 5, 2023 | News Release
Vancouver, BC, Canada, September 5, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”) a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies is pleased to announce that Viewpoint, the educational... 
by Defence Therapeutics | Jul 18, 2023 | News Release
Vancouver, BC, Canada, July 18, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), is pleased to announce that it has successfully reached the first milestone established in the Collaboration Agreement with Orano Support SAS on behalf of Orano SA... 
by FiveSenses | Jul 4, 2023 | News Release
Vancouver, BC, Canada, July 4, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”) a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies is pleased to announce its collaboration with Viewpoint... 
by FiveSenses | Jun 28, 2023 | News Release
Vancouver, BC, Canada, June 28, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”) is a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies. Sitting at the core of its innovative technologies is... 
by Defence Therapeutics | Jun 16, 2023 | News Release
Vancouver, BC, Canada, June 16th 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is pleased to announce that it reached...
Recent Comments